Eyegate Pharmaceuticals Inc. (EYEG) Declined -6.96% or -0.03 To Price $0.46 On Tuesday


Eyegate Pharmaceuticals Inc. (EYEG) declined -6.96% or -0.03 to $0.46. It is near 144704 shares traded, which is 42.33% compare to the average total volume 341817. The market cap of EYEG is $19.80 million. The year to date change is -2.73%. The 52 week price range is from $0.28 to $1.18. Price of EYEG have changed 1.66% during last week. It have changed 2.66% over last month, 61.95% over last 3 months, -7.57% over last 6 months and -58.48% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for EYEG is 0.49. It is 6.52% above current price. The 200-day Moving Averages for EYEG is 0.49. It is 6.52% above current price. The 52-week High is 1.18. It is 156.52% from the current price. The 52-week Low is 0.28. It is -39.13% from current price.

There are some statistics of EYEG. It is has market cap $19.80 million. The share outstanding is 43.44 million. The average volume is 341817. The percent of top 15 Institution holding is 40.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of EYEG is -188.71%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of EYEG is -67.95%.


Tags:

Share this post